<?xml version="1.0" encoding="UTF-8"?>
<study api_version="0.6">
  <id>162</id>
  <name>Chlamydia trachomatis global diversity project</name>
  <active>true</active>
  <user_id>112</user_id>
  <followers>
    <follower>
      <login>chc</login>
      <email>chc@sanger.ac.uk</email>
      <name>Craig Corton</name>
      <id>101</id>
    </follower>
    <follower>
      <login>sh16</login>
      <email>sh16@sanger.ac.uk</email>
      <name>Simon Harris</name>
      <id>155</id>
    </follower>
    <follower>
      <login>deh</login>
      <email>deh@sanger.ac.uk</email>
      <name>David Harris</name>
      <id>138</id>
    </follower>
    <follower>
      <login>hss</login>
      <email>hss@sanger.ac.uk</email>
      <name>Helena Seth-Smith</name>
      <id>229</id>
    </follower>
  </followers>
  <managers>
    <manager>
      <login>chc</login>
      <email>chc@sanger.ac.uk</email>
      <name>Craig Corton</name>
      <id>101</id>
    </manager>
    <manager>
      <login>jm15</login>
      <email>jm15@sanger.ac.uk</email>
      <name>Jacqueline McQuillan</name>
      <id>67</id>
    </manager>
    <manager>
      <login>nds</login>
      <email>nds@sanger.ac.uk</email>
      <name>Nishadi De Silva</name>
      <id>383</id>
    </manager>
  </managers>
  <owners>
    <owner>
      <login>tfelt</login>
      <email>tfelt@sanger.ac.uk</email>
      <name>Theresa Feltwell</name>
      <id>112</id>
    </owner>
  </owners>
  <!-- Family has been deprecated -->
  <family_id></family_id>
  <created_at>2008-10-02 10:51:44 +0100</created_at>
  <updated_at>2010-09-10 13:32:17 +0100</updated_at>
  <descriptors>
    <descriptor>
      <name>SNP study ID</name>
      <value></value>
    </descriptor>
    <descriptor>
      <name>What is the reason for preventing data release?</name>
      <value></value>
    </descriptor>
    <descriptor>
      <name>ArrayExpress Accession Number</name>
      <value></value>
    </descriptor>
    <descriptor>
      <name>Please explain the reason for delaying release (e.g., pre-existing collaborative agreement)</name>
      <value></value>
    </descriptor>
    <descriptor>
      <name>Alignments in BAM</name>
      <value>true</value>
    </descriptor>
    <descriptor>
      <name>Reason for delaying release</name>
      <value></value>
    </descriptor>
    <descriptor>
      <name>Comment regarding prevention of data release and approval</name>
      <value></value>
    </descriptor>
    <descriptor>
      <name>How is the data release to be timed?</name>
      <value>standard</value>
    </descriptor>
    <descriptor>
      <name>Policy</name>
      <value></value>
    </descriptor>
    <descriptor>
      <name>Study description</name>
      <value>Chlamydia trachomatis is the most common cause of sexually transmitted infections in the UK, a statistic which is also reflected globally. There are two biovariants of C. trachomatis: trachoma and lyphogranuloma venereum (LGV). Trachoma isolates are non-invasive, whereas the LGV strains are invasive causing a disseminating infection of the local draining lymph nodes. Genome analysis has shown that the ocular and the genital trachoma isolates are 99.6 % identical at the sequence level and only show small differences in overall gene content. However, differences in coding potential, and the loss of function through point mutation, have been used to subdivide the trachoma strains into those associated with ocular and genital infections. We have previously sequenced a  two LGV isolates; a long-term laboratory passaged strain and the recent &#8216;epidemic&#8217; clinical LGV isolate causing proctitis. From these strains it was evident that there were no whole gene differences and that the recent epidemic isolate was a classical LGV isolate and has been circulating in the human population for a long time: an old strain causing a new disease. We have now put together a global collection of LGV isolates and are a sequencing them to determine the global phylogeny of this pathogen.. This data is part of a pre-publication release. For information on the proper use of pre-publication data shared by the Wellcome Trust Sanger Institute (including details of any publication moratoria), please see http://www.sanger.ac.uk/datasharing/</value>
    </descriptor>
    <descriptor>
      <name>EGA Policy Accession Number</name>
      <value></value>
    </descriptor>
    <descriptor>
      <name>Will you be using WTSI's standard access agreement?</name>
      <value></value>
    </descriptor>
    <descriptor>
      <name>Study name abbreviation</name>
      <value></value>
    </descriptor>
    <descriptor>
      <name>Does this study contain samples that are contaminated with human DNA which must be removed prior to analysis?</name>
      <value>Yes</value>
    </descriptor>
    <descriptor>
      <name>Study Visibility</name>
      <value>Hold</value>
    </descriptor>
    <descriptor>
      <name>Delay for</name>
      <value></value>
    </descriptor>
    <descriptor>
      <name>SNP parent study ID</name>
      <value></value>
    </descriptor>
    <descriptor>
      <name>Comment regarding data release timing and approval</name>
      <value></value>
    </descriptor>
    <descriptor>
      <name>EGA DAC Accession Number</name>
      <value></value>
    </descriptor>
    <descriptor>
      <name>Has this been approved?</name>
      <value></value>
    </descriptor>
    <descriptor>
      <name>Has the delay period been approved by the data sharing committee for this project?</name>
      <value></value>
    </descriptor>
    <descriptor>
      <name>What is the data release strategy for this study?</name>
      <value>open</value>
    </descriptor>
    <descriptor>
      <name>Are all the samples to be used in this study commercially available, unlinked anonymised cell-lines?</name>
      <value>No</value>
    </descriptor>
    <descriptor>
      <name>Do any of the samples in this study contain human DNA?</name>
      <value>No</value>
    </descriptor>
    <descriptor>
      <name>ENA Study Accession Number</name>
      <value>ERP000089</value>
    </descriptor>
    <descriptor>
      <name>Title</name>
      <value>Chlamydia trachomatis global diversity project</value>
    </descriptor>
    <descriptor>
      <name>Abstract</name>
      <value>To sequence a global collection of Chlamydia trachomatis LGV isolates in order to determine the global phylogeny.
</value>
    </descriptor>
    <descriptor>
      <name>ENA Project ID</name>
      <value>0</value>
    </descriptor>
    <descriptor>
      <name>Study Type</name>
      <value>Whole Genome Sequencing</value>
    </descriptor>
    <descriptor>
      <name>Faculty Sponsor</name>
      <value>Julian Parkhill</value>
    </descriptor>
    <descriptor>
      <name>What sort of study is this?</name>
      <value>genomic sequencing</value>
    </descriptor>
    <descriptor>
      <name>Reference Genome</name>
      <value></value>
    </descriptor>
  </descriptors>
</study>
